ABSORBINE POWER GEL 4 % — DIN 01999524
MENTHOL : 4 % CHLOROXYLENOL : .5 % · W.F. YOUNG, INC. · GEL · wholesale supply in Canada
Health Canada status: DORMANT
What is ABSORBINE POWER GEL?
ABSORBINE POWER GEL 4 % contains MENTHOL : 4 % CHLOROXYLENOL : .5 %. It is listed in the Health Canada Drug Product Database under DIN 01999524, held by W.F. YOUNG, INC., supplied as GEL for TOPICAL administration. Health Canada currently lists it as dormant, status dated 27-Jul-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
Is there a generic Various in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
43 holders have a Canadian DIN containing Various, across 59 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| CHATTEM CANADA | 5 | 0 | FLEX-ALL 454 10%, FLEX-ALL 454 16% GEL, FLEX-ALL 454 GEL 7%, FLEXALL ICE, FLEXALL MUSCLE (ORIGINAL STRENGTH) | No marketed DIN |
| NATURLAND CANADA INC. | 3 | 0 | INNO RHEUMA MASSAGE OIL, NATURLAND INNO RHEUMA CREAM, NATURLAND SPORTS CREAM | No marketed DIN |
| SCOTT CHEMICAL CANADA | 3 | 0 | ARTIC ICE ANALGESIC GEL 2.5%, POLAR ICE ANALGESIC GEL 2.5%, SOOTHING ICE RUB ANALGESIC GEL | No marketed DIN |
| STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | 3 | 0 | CAMPHOR SPIRIT LIQ 10%, CAMPHORATED OIL 20%, SOOTHING ICE RUB | No marketed DIN |
| BRIDGES CONSUMER HEALTHCARE LLC | 2 | 0 | ABSORBINE JR EXTRA STRENGTH LINIMENT, ABSORBINE JR LINIMENT | No marketed DIN |
| D.C. LABS LIMITED | 2 | 0 | CAMPHORATED OIL 20%, SPIRIT OF CAMPHOR | No marketed DIN |
| DAWSON TRADERS LTD. | 2 | 0 | CAMPHOR SPIRIT, CAMPHORATED OIL LINIMENT | No marketed DIN |
| PFIZER CANADA INC., CONSUMER HEALTHCARE DIVISION | 2 | 0 | BEN-GAY ICE, BENGAY EXTRA STRENGTH ICE | No marketed DIN |
| PRODUITS MARC-O (1987) INC., DIVISION OF TECHNILAB INC. | 2 | 0 | CAMPHO REX, MARCO RUB CAMPHORATED ONT | No marketed DIN |
| THE MENTHOLATUM COMPANY OF CANADA LTD | 2 | 0 | DEEP COLD ARTHRITIC HAND LOTION 2%, OBUS FORM THERAPEUTIC ICE GEL | No marketed DIN |
| BAYER INC CONSUMER CARE | 1 | 0 | MYOFLEX ICE COLD-GEL 4% | No marketed DIN |
| CARTER PRODUCTS, DIVISION OF CARTER WALLACE NS INC. | 1 | 0 | ANTIPHLOGISTINE RUB A-535 ICE GEL 4% | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 4 % |
|---|---|
| Dosage form | GEL |
| Route | TOPICAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Various |
|---|---|
| ATC code | M02AX10 |
| AHFS class | 84:24.04 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 01999524 |
|---|---|
| DIN (unpadded, as printed on some documents) | 1999524 |
| Brand name | ABSORBINE POWER GEL |
| Generic / active ingredient | MENTHOL : 4 % CHLOROXYLENOL : .5 % |
| Market authorization holder | W.F. YOUNG, INC. |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | M02AX10 |
| ATC anatomical main group | M — Musculo-skeletal system |
| ATC therapeutic subgroup | M02AX |
| Current status | DORMANT |
| Status date | 27-Jul-2018 |
| Original market date | 1993-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 59 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ABSORBINE JR EXTRA STRENGTH LINIMENT | 0.5 % | LIQUID | BRIDGES CONSUMER HEALTHCARE LLC | CANCELLED POST MARKET | 01942271 |
| ABSORBINE JR LINIMENT | 1.25 % | SOLUTION | BRIDGES CONSUMER HEALTHCARE LLC | CANCELLED POST MARKET | 01942301 |
| ANTIPHLOGISTINE RUB A-535 ICE GEL 4% | 4 % | GEL | CARTER PRODUCTS, DIVISION OF CARTER WALLACE NS INC. | CANCELLED POST MARKET | 02034417 |
| ARTHRO RHEUMA CREAM | 1.5 % | CREAM | NATURLAND LTD. | CANCELLED POST MARKET | 02240103 |
| ARTIC ICE ANALGESIC GEL 2.5% | 2.5 % | GEL | SCOTT CHEMICAL CANADA | CANCELLED POST MARKET | 01915126 |
| BALMINIL CAMPHORUB | 6.5 % | OINTMENT | ROUGIER PHARMA DIVISION OF RATIOPHARM INC | CANCELLED POST MARKET | 02233025 |
| BEN-GAY ICE | 2.5 % | GEL | PFIZER CANADA INC., CONSUMER HEALTHCARE DIVISION | CANCELLED POST MARKET | 02230265 |
| BENGAY EXTRA STRENGTH ICE | 100 MG | CREAM | PFIZER CANADA INC., CONSUMER HEALTHCARE DIVISION | CANCELLED POST MARKET | 02241251 |
| BIOFREEZE | 0.2 % | GEL | PERFORMANCE HEALTH INC. | CANCELLED POST MARKET | 02237710 |
| BLUE ICE 2.5% | 2.5 % | GEL | LABORATOIRES DELON (1990) INC | CANCELLED POST MARKET | 02244600 |
2 · Same class — other molecules in ATC M02AX
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Various | ABSORBINE JR EXTRA STRENGTH LINIMENT · ABSORBINE JR LINIMENT · ABSORBINE POWER GEL · ANTIPHLOGISTINE RUB A-535 ICE GEL 4% · +54 more | 59 | 0 | Not in Canada |
| Dimethyl Sulfoxide | KEMSOL LIQUID 70% | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC M02A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| M02AC | Preparations With Salicylic Acid Derivatives | 120 | 11 |
| M02AA | Bufexamac · Diclofenac | 16 | 8 |
| M02AB | Capsaicin · Capsaicin And Similar Agents · Zucapsaicin | 26 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.